MoonLake Immunotherapeutics CSO Kristian Reich sells 16,105 shares for $322,261.05 - MLTX News | RalliesMoonLake Immunotherapeutics CSO Kristian Reich sells 16,105 shares for $322,261.05
M
MLTX• CSO discloses share sale
- MoonLake Immunotherapeutics Chief Scientific Officer Kristian Reich disclosed a sale of 16,105 Class A ordinary shares on July 15, 2026.
- Shares sold at a weighted average price of $20.01, implying proceeds of about $322,261.
- Indirect holdings fell to 2,808,446 shares following the transaction.
- Direct holdings were reported at 35,389 shares after the filing.
FNUC
•
